welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
scientific articles
Celecoxib in a 12-Year-Old Boy with Familial Adenomatous Polyposis
source: International journal of clinical pharmacology and therapeutics
year: 2010
authors: Pérez-Segura P, Bodas A, Sereno M, Martínez-Amores B, Olivera H, Díaz S, López-Asenjo J A, Puente J, Maluenda C, Díaz-Rubio E
summary/abstract:Familial Adenomatous Polyposis (FAP) is an autosomal dominant disorder characterized by colonic polyps in early adult life. Children with this disease are at risk for colonic cancer, so prophylactic colectomy is the standard treatment to prevent this complication. Chemoprevention experience with NSAIDs in children is exceptional. This case report describes our experience with Celecoxib, a COX-2 inhibitor, in a 12-year-old boy.
organization: Hospital Clínico San Carlosread more full text source
expertly curated content related to this topic
- Huntsman Cancer Institute study delves into reasons why preventive drug is effectiveA potent preventive treatment for people...
- Identification of 5 Novel Germline APC Mutations and Characterization of Clinical Phenotypes in Japanese Patients wi...BACKGROUND : Familial adenomatous polypo...
- Ileal Pouch-Anal Anastomosis: Points of ControversyRestorative proctocolectomy with ileal p...
- Cancer Prevention Pharmaceuticals, Inc. and Tillotts Pharma AG Sign Licensing Agreement for CPP-1X/sulindac in Europ...Cancer Prevention Pharmaceuticals, Inc. ...
- Celecoxib in Preventing Colorectal Cancer in Young Patients With a Genetic Predisposition for Familial Adenomatous P...RATIONALE: Chemoprevention is the us...
- Proctocolectomy for Ulcerative Colitis or Familial Adenomatous Polyposishttps://www.youtube.com/watch?v=zlxBwxKX...
- Genetics, Inheritance and Strategies for Prevention in Populations at High Risk of Colorectal Cancer (CRC)Hereditary forms of colorectal cancer ac...
English
Portuguese
Spanish